Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain Management in Outpatient Urologic Procedures
NCT03393364Phase 1Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Apr 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of oxycodone and ketorolac in postoperative pain (2 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Pain control at 6 weeks. Started Apr 2018; status: completed.
02
Drugs
oxycodoneketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03393364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03393364.